Expert: High-affinity ligand for synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and exhibiting antiepileptic activity through a novel mechanism.
Everyday: Binds to a protein in brain cells that helps control the release of brain chemicals, reducing seizures.
Brivaracetam, a next-generation anticonvulsant with high-affinity SV2A binding for partial-onset seizures. Designed as a more potent and selective follow-on to levetiracetam (Keppra) with improved tolerability.